This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Medically reviewed by Qin Rao, MD Gastric sleeve and gastric bypass are two types of weight loss surgery. They are effective ...

A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...

A daily pill could be as effective for weight loss as popular drugs like Wegovy and Ozempic, providing an alternative to the ...

A WOMAN who went on Mounjaro in a bid to lose weight has issued an urgent warning to anyone considering the fat jab. Lucinda explained that the weight “piled on” during the Covid-19 ...

General Hospital April 15 Episode Recap: Elizabeth Gets a Warm Welcome as She Returns Home; Details Inside The Bold and the Beautiful April 15 Episode Recap: Will Warns Luna to Stay Away, Electra ...

Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting its ambition to compete with Novo Nordisk and Eli Lilly. This setback ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient experienced potential drug-induced liver injury which resolved after the ...

On Monday the company said it was discontinuing development of a weight-loss drug in pill form. File Photo by John Angelillo/UPI ...

Pfizer opens new tab on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient experienced potential drug-induced liver injury which resolved ...

Pfizer shares moved lower in premarket trading Monday after the drugmaker said it is scrapping its experimental weight-loss pill danuglipron, keeping the company on the sidelines of the booming ...